Immunology of Biofilms (R21) | Apply Online

Opportunity Summary:

The Immunology of Biofilms (R21) funding opportunity (PA 06 538) is an NIH grant announcement from the National Institute of Dental and Craniofacial Research (NIDCR) focused on early-stage, exploratory research that clarifies how the human host responds immunologically to microbial biofilms. It grew out of two NIDCR-led advisory meetings (the Biofilm Network Initiative Meeting in June 2004 and the Oral Mucosal Immunology Advisory Meeting in October 2004), reflecting a broader push to move biofilm research beyond describing microbial communities and toward understanding the immune mechanisms that drive disease persistence, tissue damage, and treatment resistance. The overall intent is practical and translational: generate insights that can lead to better ways to diagnose, prevent, and treat infections where biofilms are central to pathogenesis.

A key emphasis of the announcement is collaboration across disciplines and across borders. The FOA explicitly encourages domestic and international teams that combine clinical expertise (for example, dentists, physicians, and nurses who see biofilm-associated infections in real patients) with basic and quantitative sciences (such as immunology, microbiology, materials science, and mathematics). The logic is that biofilm-associated infections are not just microbiology problems; they involve host immunity, physical structure and materials interactions, and complex dynamics that often benefit from modeling and systems approaches. By intentionally linking clinicians with bench scientists and other specialists, the program aims to sharpen the definition of clinically relevant questions and speed the translation of mechanistic findings into strategies that matter in real-world care settings.

The grant mechanism is the NIH Exploratory/Developmental R21, which is designed for high-impact, early-phase ideas that may be too preliminary for a larger R01. This FOA runs in parallel with an R01 version of the same scientific scope (PA 06 537), giving applicants a pathway to pursue the same overall theme at either exploratory (R21) or more mature (R01) project scales depending on readiness. Under the R21 rules described here, the maximum project period is two years. The budget limits cap direct costs at $275,000 total over the two-year period, with an additional constraint that no more than $200,000 in direct costs may be requested in any single year. This structure signals that NIH is looking for focused, well-scoped projects that can quickly generate proof-of-concept data, new tools, or new mechanistic understanding that can later be expanded.

In terms of what gets funded, the announcement does not promise a fixed pot of money or a guaranteed number of awards. Instead, awards are contingent on the availability of funds and on the volume and quality of applications received. The number of awards, the size of each award, and the final total dollars committed are expected to vary based on scientific merit, proposed duration, and costs. In other words, the competition is largely merit-driven, and applicants should expect their proposals to be evaluated in the context of both scientific value and appropriateness of scope for an R21.

Eligibility is broad and includes most major research-performing and community-serving institution types. Applicants can come from for-profit or nonprofit organizations, public or private institutions (including universities, colleges, hospitals, and laboratories), units of state and local governments, eligible federal agencies, and a range of community and mission-driven entities such as faith-based or community-based organizations. Tribal entities are specifically included, covering federally recognized tribes, other tribal governments, and tribally designated organizations. Importantly, foreign institutions are eligible to apply, reinforcing the program goal of encouraging international collaboration where it strengthens the science or clinical relevance.

The program is open to any qualified Project Director/Principal Investigator with the expertise, resources, and institutional support to carry out the work. NIH also reiterates its standard inclusion encouragement: individuals from underrepresented racial and ethnic groups and individuals with disabilities are strongly encouraged to apply. Investigators are allowed to submit more than one application as long as each proposal is scientifically distinct, which can be helpful for teams pursuing multiple angles on host-biofilm immunology (for example, one project focusing on mucosal immune mechanisms and another on biomaterials-associated biofilms), provided the overlap is managed appropriately.

Administratively, this is a discretionary grant opportunity in the health area, associated with CFDA 93.121 (Oral Diseases and Disorders Research), and it does not require cost sharing or matching. The announcement was posted August 29, 2006, used multiple receipt dates, and ultimately closed and archived in 2009 (with a current closing date listed as September 7, 2009, and an archive date of October 7, 2009). The official full announcement link is provided through the NIH grants guide, and technical access issues were routed to the NIH Office of Extramural Research webmaster contact listed in the notice.

Taken together, the FOA is best viewed as a targeted invitation for creative, cross-disciplinary R21 projects that explain how immune responses interact with biofilm biology to shape infection outcomes, with the explicit expectation that this knowledge will support better clinical approaches to stubborn, biofilm-driven infectious diseases, particularly those relevant to oral and mucosal health but not necessarily limited to them.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Mechanisms, Models, Measurement, and Management in Pain Research (R21)

Previous opportunity: Translational Research for the Prevention and Control of Diabetes and Obesity (R18)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 06 538

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 06 538) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 06 538", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.